2015
DOI: 10.1007/s00134-014-3642-8
|View full text |Cite
|
Sign up to set email alerts
|

Presepsin: solving a soluble (CD14) problem in sepsis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0
6

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 22 publications
0
12
0
6
Order By: Relevance
“…Soluble forms of CD14 are produced and released into circulation either by secretion following phagocytosis or through proteolytic cleavage on activated monocytes. Presepsin is a 13-kDa truncated form consisting of 64 amino acid residues [ 12 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Soluble forms of CD14 are produced and released into circulation either by secretion following phagocytosis or through proteolytic cleavage on activated monocytes. Presepsin is a 13-kDa truncated form consisting of 64 amino acid residues [ 12 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5] When a pro-inflammatory cascade is activated against infectious agents, it is released following phagocytosis or released into circulation by breakdown of CD14 via the proteolytic pathway. 4,5 Its high specificity for bacterial infections is one of its most important characteristics. 6 Several studies have shown that PRE-SEP is superior to procalcitonin (PCT) and C-reactive protein…”
mentioning
confidence: 99%
“…In a healthy population, the serum concentration of sCD14 is at microgram level (10), and is an indicator of macrophage and monocyte activation. Presepsin is an indirect sepsis marker that forms with degradation of sCD14 (11,14). Elevated levels of presepsin have been found in various infectious diseases such as acquired immunodeficiency syndrome (15), meningitis (16), hepatitis (17), sepsis (11), periodontitis (18), and malaria (19).…”
Section: Discussionmentioning
confidence: 99%